Panbela Therapeutics’ stock skyrockets after positive FDA news on child cancer treatment

Shares of Panbela Therapeutics Inc. skyrocketed again Tuesday, following positive news from the U.S. Food and Drug Administration regarding a treatment for child cancer.

Previous post This one insight can transform your 401(k) — and it’s hiding in plain sight
Next post Don’t underestimate the power of a simple ‘hello’